Drug intelligence / Profile preview

Aquaprin Cold & Flu

Development stage
Unknown
Lead developer
PharmStar
Modality
Small Molecules
Administration
Oral
01

Overview

Aquaprin Cold & Flu is an over-the-counter (OTC) effervescent medication developed for the relief of symptoms associated with the common cold and influenza, such as fever, minor aches, pains, and nasal congestion. The product is built upon the **Aquaprin** platform, which features an FDA-approved effervescent formulation of **aspirin** (acetylsalicylic acid). The effervescent delivery system is designed to enhance the rate of absorption and provide a faster onset of therapeutic action compared to traditional solid oral tablets. In its 'Cold & Flu' iteration, the formulation typically combines the analgesic and antipyretic properties of aspirin with additional active ingredients such as a decongestant (e.g., phenylephrine) and/or an antihistamine (e.g., chlorpheniramine). The intellectual property and commercialization rights for the brand were notably acquired by PharmStar Pharmaceuticals (via a reverse acquisition of PharmStar Incorporated) in 2011 to facilitate fundraising and market expansion.

Brand names
Aquaprin Cold & FluAquaprin
Other names
Aquaprin Cold and Flu
02

Targets

PTGS2 (Prostaglandin-Endoperoxide Synthase 2)ADRA1A (α1A)PGHS-1 (Prostaglandin G/H Synthase 1)HRH1 (Histamine H1 Receptor)

Beyond the preview

Go deeper on Aquaprin Cold & Flu.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Aquaprin Cold & Flu.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call